Press Releases
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Kannaway® Connect App
SAN DIEGO, Oct. 17, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA), announced today that subsidiary Kannaway®, the…
October 17, 2018
0 Comments
Medical Marijuana, Inc. CEO to Speak, Subsidiary HempMeds® to Exhibit at Cannabis World Congress in Boston
SAN DIEGO, Oct. 16, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded…
October 16, 2018
0 Comments
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Speaks at Fourth International Congress of Neuroscience in São Paulo, Brazil
SAN DIEGO, Oct. 15, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis…
October 15, 2018
0 Comments
Medical Marijuana, Inc. CEO to Speak at CBD Outlook Conference on Humulus-Derived CBD
SAN DIEGO, Oct. 11, 2018 -- Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company…
October 11, 2018
0 Comments
Medical Marijuana, Inc. Launches Dixie Botanicals Canada®
Innovative Lifestyle Brand Introduces CBD-only Products to the Canadian Market SAN DIEGO, Oct. 10, 2018…
October 10, 2018
0 Comments
Medical Marijuana, Inc. Announces Q3 2018 as the Largest Sales Bookings Quarter in Company History
SAN DIEGO, Oct. 9, 2018 -- Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in…
October 9, 2018
0 Comments
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Single Serving Size Sample Packs
SAN DIEGO, October 8, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded…
October 8, 2018
0 Comments
Medical Marijuana, Inc. Launches Real Scientific Canada™ Throughout Canada
San Diego, CA – October 4, 2018 - Medical Marijuana Inc. (OTC: MJNA), the first-ever…
October 4, 2018
0 Comments
Medical Marijuana, Inc. Subsidiary Kannaway® Rapid Revenue Growth Featured in Top Direct Selling Industry Publication
SAN DIEGO, Oct. 3, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis…
October 3, 2018
0 Comments